Reversal of subtype-selectivity and function by the introduction of a para -benzamidyl substituent to N -cyclopropylmethyl nornepenthone

Linghui Kong,Kuan Ning,Xiao Liu,Jiashuo Lu,Baiyu Chen,Rongrong Ye,Zixiang Li,Shuang Jiang,Siyuan Tang,Jing-Rui Chai,Yun Fang,Yingjie Lan,Xiaobo Mai,Qiong Xie,Jinggen Liu,Liming Shao,Wei Fu,Yujun Wang,Wei Li

DOI: https://doi.org/10.1016/j.ejmech.2023.115589

IF: 7.088

2023-06-29

European Journal of Medicinal Chemistry

Abstract:The discovery and development of novel μ-opioid receptor (MOR) antagonists is a significant area to combat Opioid Use Disorder (OUD). In this work, a series of para-substituted N -cyclopropylmethyl-nornepenthone derivatives were designed and synthesized and pharmacologically assayed. Compound 6a was identified as a selective MOR antagonist both in vitro and in vivo . Its molecular basis was elucidated using molecular docking and MD simulations. A subpocket on the extracellular side of the TM2 domain of MOR, in particular the residue Y 2.64 , was proposed to be responsible for the reversal of subtype selectivity and functional reversal of this compound.

chemistry, medicinal